PUMA BIOTECHNOLOGY INC shareholders Q2 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
BUCKINGHAM STRATEGIC PARTNERS, LLC 19,220$67,8470.00%
Connor, Clark & Lunn Investment Management Ltd. 199,767$705,1780.00%
Assenagon Asset Management S.A. 223,321$788,3230.00%
Jump Financial, LLC 19,500$68,8350.00%
TWO SIGMA ADVISERS, LP 344,600$1,216,4380.00%
LSV ASSET MANAGEMENT 194,551$6870.00%
SEI INVESTMENTS CO 285,598$1,008,1490.00%
FEDERATED HERMES, INC. 181,941$642,2520.00%
MARSHALL WACE, LLP 224,793$793,5190.00%
Patriot Financial Group Insurance Agency, LLC 7,700$2,7180.00%
TWO SIGMA INVESTMENTS, LP 106,073$374,4380.00%
Cubist Systematic Strategies, LLC 21,692$76,5730.00%
Lindbrook Capital, LLC 2,793$9,8590.00%
Aspire Private Capital, LLC 700$2,4710.00%
Squarepoint Ops LLC 90,987$321,1840.00%
Citadel Advisors 219,436$774,6090.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 32,200$113,6660.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 33,200$117,1960.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 100,610$355,1530.00%
SIMPLEX TRADING, LLC 5,350$180.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.